首页> 外国专利> New mutants of Gram-negative mucosal bacteria and their use in vaccines

New mutants of Gram-negative mucosal bacteria and their use in vaccines

机译:革兰氏阴性粘膜细菌的新突变体及其在疫苗中的应用

摘要

It is possible to inactivate the early stage of lipid A synthesis of mucosal gram negative bacteria without compromising cell viability. In particular the lpxA gene in N. meningitidis was mutated and resulting lpxA knockout mutants were found to be completely lipopolysaccharide (LPS)-deficient. The major outer membrane proteins (OMPs) were detected in normal amounts. The finding provides important implications for understanding of structure and biogenesis of the outer membrane. On a practical level, the availability of LPS-deficient mutants of pathogenic mucosal bacteria such as N. meningitidis opens up new avenues to vaccine development. It enables easy isolation of endotoxin-free purified proteins, outer membranes or even whole-cell preparations for use in immunisation.
机译:可以灭活粘膜革兰氏阴性细菌的脂质A合成的早期阶段,而不会损害细胞活力。特别是脑膜炎奈瑟氏球菌中的lpxA基因发生了突变,发现所得的lpxA基因敲除突变体完全缺乏脂多糖(LPS)。检出的主要外膜蛋白(OMPs)含量正常。这一发现为理解外膜的结构和生物发生提供了重要的启示。在实践上,LPS缺陷型致病性粘膜细菌突变株(如脑膜炎奈瑟氏球菌)的可获得性为疫苗开发开辟了新途径。它可以轻松分离用于免疫的不含内毒素的纯化蛋白,外膜甚至全细胞制剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号